Adequate histologic sampling of breast core needle biopsies

Archives of Pathology and Laboratory Medicine

Volumn 125, Issue 8, 2001, Pages 1055-1057

  Renshaw, A A ^a  

^a BAPTIST HOSPITAL OF MIAMI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BREAST BIOPSY; BREAST CANCER; CANCER SURGERY; CARCINOMA IN SITU; CELL PROLIFERATION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTRADUCTAL CARCINOMA; MAJOR CLINICAL STUDY; NEEDLE BIOPSY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOPSY, NEEDLE; BREAST; BREAST NEOPLASMS; CARCINOMA, INTRADUCTAL, NONINFILTRATING; FEMALE; HOSPITALS, COMMUNITY; HUMANS; HYPERPLASIA; MIDDLE AGED;

EID: 0034904310     PISSN: 00039985     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Large-core needle biopsy of non-palpable breast lesions
2. Follow-up of benign results of stereotactic core breast biopsy
3. Follow-up of breast lesions diagnosed as benign with stereotactic core-needle biopsy: Frequency of mammographic change and false-negative rate
4. Diagnostic accuracy of large-core needle biopsy for nonpalpable breast disease: A meta-analysis
5. Accuracy and complication rates of US-guided vacuum-assisted core breast biopsy: Initial results
6. Large-needle core biopsy: Nonmalignant breast abnormalities evaluated with surgical excision or repeat core biopsy
7. Comparison of histologic diagnosis between stereotactic core needle biopsy and open surgical biopsy
8. Stereotaxic 14 gauge breast biopsy: How many core biopsy specimens are needed?
9. Adequate tissue sampling of prostate core needle biopsies
10. Diagnostic effect of complete histologic sampling of prostate needle biopsies
11. How often are diagnostic features missed with less extensive histologic sampling of prostate needle biopsy specimens
12. Needle biopsies of the prostate: What constitutes adequate histologic sampling?
13. Usefulness of Telfa pads in the histologic assessment of stereotactic-guided breast biopsy specimens
14. Interobserver reproducibility in the diagnosis of ductal proliferative breast lesions using standardized criteria
15. How thoroughly should needle localization breast biopsies be sampled for microscopic examination? A prospective mammographic/pathologic correlative study
16. Histologic sampling of grossly benign breast biopsies: How much is enough?
17. Stereotactic, automated, large-core needle biopsy of nonpalpable breast lesions: False-negative and histologic underestimation rates after long-term follow-up
18. Evaluation of stereotactic core needle biopsy (SCNB) of the breast at a single institution
19. Mammographic-histopathologic correlation of large-core needle biopsies of the breast
20. Histologic correlation of image-guided core biopsy with excisional biopsy of nonpalpable breast lesions
21. Atypical ductal hyperplasia: Histologic underestimation of carcinoma in tissue harvested from impalpable breast lesions using 11-gauge stereotactically guided directional vacuum-assisted biopsy
22. Atypical ductal hyperplasia diagnosed at stereotaxic core biopsy of breast lesions: An indication for surgical biopsy
23. Stereotaxic large-core needle biopsy of 450 nonpalpable breast lesions with surgical correlation in lesions with cancer or atypical hyperplasia
24. Surgical biopsy findings in patients with atypical hyperplasia diagnosed by stereotaxic core needle biopsy
25. Stereotactic breast biopsy of atypical ductal hyperplasia and ductal carcinoma in situ lesions: Improved accuracy with directional, vacuumassisted biopsy
26. Appropriate management of atypical ductal hyperplasia diagnosed by stereotactic core needle breast biopsy
27. Accuracy of stereotactic core-needle breast biopsy in atypical ductal hyperplasia
28. Association of breast cancer with the finding of atypical ductal hyperplasia at core breast biopsy
29. Atypical hyperplasia in the era of stereotactic core needle biopsy
30. Atypical ductal hyperplasia in breast core needle biopsies: Correlation of size of the lesion, complete removal of the lesion, and the incidence of carcinoma in follow-up biopsies